View More View Less
  • 1 Debreceni Egyetem, Klinikai Központ Neurológiai Klinika Debrecen Móricz Zs. krt. 22. 4032
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $1,070.00

Az egyik kevésbé jól dokumentált, potenciálisan módosítható stroke-kockázati faktor az obstruktív alvási apnoe szindróma. Obstruktív alvási apnoe jelenléte esetén nő a cardiovascularis morbiditás és mortalitás, ezen belül a stroke-kockázat is. Jelen közleményben a szerző azokat a patofiziológiai tényezőket foglalja össze, amelyek növelik a stroke-kockázatot alvási apnoe jelenléte esetén. Orv. Hetil., 2014, 155(16), 615–619.

  • Young, T., Palta, M., Dempsey, J., et al.: The occurrence of sleep-disordered breathing among middle-aged adults. N. Engl. J. Med., 1993, 328(17), 1230–1235.

  • Torzsa, P., Novák, M., Mucsi, I., et al.: The role of family physicians in the recognition and screening of obstructive sleep apnea. [A családorvos szerepe az obstruktív alvási apnoe szűrésében, felismerésében.] Orv. Hetil., 2008, 149(48), 2283–2290. [Hungarian]

  • Epstein, L. J., Kristo, D., Strollo, P. J. Jr., et al.: Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. Adult Obstructive Sleep Apnea Task Force of the American Academy of Sleep Medicine. J. Clin. Sleep Med., 2009, 5(3), 263–276.

  • Kushida, C. A., Littner, M. R., Morgenthaler, T., et al.: Practice parameters for the indications for polysomnography and related procedures: an update for 2005. Sleep, 2005, 28(4), 499–521.

  • Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep, 1999, 22(5), 667–689.

  • Giles, T. L., Lasserson, T. J., Smith, B. J., et al.: Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst. Rev., 2006, 3, CD001106.

  • Gay, P., Weaver, T., Loube, D., et al.: Evaluation of positive airway pressure treatment for sleep related breathing disorders in adults. Sleep, 2006, 29(3), 381–401.

  • Torzsa, P., Kalabay, L., Ádám, Á., et al.: Obstructive sleep apnea: clinical importance and General Practitioner’s role in the treatment and care. [Az obstruktív alvási apnoe klinikai jelentősége, a családorvos szerepe a betegek kezelésében, valamint gondozásában.] Orv. Hetil., 2010, 151(42), 1725–1733. [Hungarian]

  • Somers, V. K., White, D. P., Amin, R., et al.: Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation, 2008, 118(10), 1080–1111.

  • Bradley, T. D., Floras, J. S.: Obstructive sleep apnoea and its cardiovascular consequences. Lancet, 2009, 373(9657), 82–93.

  • Monahan, K., Redline, S.: Role of obstructive sleep apnea in cardiovascular disease. Curr. Opin. Cardiol., 2011, 26(6), 541–547.

  • Loke, Y. K., Brown, J. W., Kwok, C. S., et al.: Association of obstructive sleep apnea with risk of serious cardiovascular events: a systematic review and meta-analysis. Circ. Cardiovasc. Qual. Outcomes, 2012, 5(5), 720–728.

  • Dong, J. Y., Zhang, Y. H., Qin, L. Q.: Obstructive sleep apnea and cardiovascular risk: meta-analysis of prospective cohort studies. Atherosclerosis, 2013, 229(2), 489–495.

  • Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Cerebrovasc. Dis., 2008, 25(5), 457–507.

  • Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N. Engl. J. Med., 1995, 333(24), 1581–1587.

  • Del Zoppo, G. J., Saver, J. L., Jauch, E. C., et al.: Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator. A science advisory from the American Heart Association/American Stroke Association. Stroke, 2009, 40(8), 2945–2948.

  • Mackey, J., Kleindorfer, D., Sucharew, H., et al.: Population-based study of wake-up strokes. Neurology, 2011, 76(19), 1662–1667.

  • Elliott, W. J.: Circadian variation in the timing of stroke onset: a meta-analysis. Stroke, 1998, 29(5), 992–996.

  • Hsieh, S. W., Lai, C. L., Liu, C. K., et al.: Obstructive sleep apnea linked to wake-up strokes. J. Neurol., 2012, 259(7), 1433–1439.

  • Somers, V. K., Dyken, M. E., Mark, A. L., et al.: Sympathetic-nerve activity during sleep in normal subjects. N. Engl. J. Med., 1993, 328(5), 303–307.

  • Somers, V. K., Dyken, M. E., Clary, M. P., et al.: Sympathetic neural mechanisms in obstructive sleep apnea. J. Clin. Invest., 1995, 96(4), 1897–1904.

  • Barta, K., Szabó, Z., Kun, C., et al.: Arrhythmias in patients with obstructive sleep apnea. [Szívritmuszavarok obstruktív alvási apnoéban.] Orv. Hetil. 2008, 149(13), 579–587. [Hungarian]

  • Beelke, M., Angeli, S., Del Sette, M., et al.: Prevalence of patent foramen ovale in subjects with obstructive sleep apnea: a transcranial Doppler ultrasound study. Sleep Med., 2003, 4(3), 219–223.

  • Gur, A. Y., Bova, I., Bornstein, N. M.: Is impaired cerebral vasomotor reactivity a predictive factor of stroke in asymptomatic patients? Stroke, 1996, 27(12), 2188–2190.

  • Cummings, K. J., Swart, M., Ainslie, P. N.: Morning attenuation in cerebrovascular CO2 reactivity in healthy humans is associated with a lowered cerebral oxygenation and an augmented ventilatory response to CO2. J. Appl. Physiol., 2007, 102(5), 1891–1898.

  • Hermann, D. M., Bassetti, C. L.: Sleep-disordered breathing and stroke. Curr. Opin. Neurol., 2003, 16(1), 87–90.

  • Von Känel, R., Dimsdale, J. E.: Hemostatic alterations in patients with obstructive sleep apnea and the implications for cardiovascular disease. Chest, 2003, 124(5), 1956–1967.

  • Von Känel, R., Loredo, J. S., Ancoli-Israel S., et al: Association between polysomnographic measures of disrupted sleep and prothrombotic factors. Chest, 2007, 131(3), 733–739.

  • Lui, M. M., Lam, D. C., Ip, M. S.: Significance of endothelial dysfunction in sleep-related breathing disorder. Respirology, 2013, 18(1), 39–46.

  • Feng, J., Zhang, D., Chen, B.: Endothelial mechanisms of endothelial dysfunction in patients with obstructive sleep apnea. Sleep Breath, 2012, 16(2), 283–294.

  • Nadeem, R., Molnar, J., Madbouly, E. M., et al.: Serum inflammatory markers in obstructive sleep apnea: a meta-analysis. J. Clin. Sleep Med., 2013, 9(10), 1003–1012.

  • Ridker, P. M., Hennekens, C. H., Buring, J. E., et al.: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med., 2000, 342(12), 836–843.

  • Ip, M. S., Lam, B., Ng, M. M., et al.: Obstructive sleep apnea is independently associated with insulin resistance. Am. J. Respir. Crit. Care Med., 2002, 165(5), 670–676.

  • Cobble, M., Bale, B.: Carotid intima-media thickness: knowledge and application to everyday practice. Postgrad. Med., 2010, 122(1), 10–18.

  • Nadeem, R., Harvey, M., Singh, M., et al.: Patients with obstructive sleep apnea display increased carotid intima media: A meta-analysis. Int. J. Vasc. Med., 2013, 2013, 839582.

  • Chambless, L. E., Folsom, A. R., Clegg, L. X., et al.: Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) Study. Am. J. Epidemiol., 2000, 151(5), 478–487.

  • Alajmi, M., Mulgrew, A. T., Fox, J., et al.:Impact of continuous positive airway pressure therapy on blood pressure in patients with obstructive sleep apnea hypopnea: a meta-analysis of randomized controlled trials.Lung, 2007, 185(2), 67–72.

  • Baessler, A., Nadeem, R., Harvey, M., et al.: Treatment for sleep apnea by continuous positive airway pressure improves levels of inflammatory markers – a meta-analysis. J. Inflamm. (Lond.), 2013, 10(1), 13.

  • Marin, J. M., Carrizo, S. J., Vicente, E., et al.: Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet, 2005, 365(9464), 1046–1053.